Cobimetinib Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with cobimetinib
H
- Hadlima (adalimumab)
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-omp) vaccine / hepatitis b pediatric vaccine
- haemophilus b conjugate (prp-t) vaccine
- haemophilus b conjugate (prp-t) vaccine / meningococcal conjugate vaccine
- Haponal (atropine / hyoscyamine / phenobarbital / scopolamine)
- Harvoni (ledipasvir / sofosbuvir)
- Havrix (hepatitis a adult vaccine)
- Havrix Pediatric (hepatitis a pediatric vaccine)
- Healthy Colon (bifidobacterium infantis / lactobacillus acidophilus)
- Hecoria (tacrolimus)
- Hemady (dexamethasone)
- hepatitis a adult vaccine
- hepatitis a adult vaccine / hepatitis b adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- Heplisav-B (hepatitis b adult vaccine)
- Hexadrol (dexamethasone)
- Hiberix (haemophilus b conjugate (prp-t) vaccine)
- HibTITER (haemophilus b conjugate (hboc) vaccine)
- HiDex (dexamethasone)
- Histolyn-Cyl (histoplasmin)
- histoplasmin
- Histoplasmin Diluted (histoplasmin)
- Hulio (adalimumab)
- human papillomavirus vaccine
- Humatrope (somatropin)
- HumatroPen (somatropin)
- Humira (adalimumab)
- Hycamtin (topotecan)
- hydrochlorothiazide / spironolactone
- hyoscyamine / phenobarbital
- Hyosophen (atropine / hyoscyamine / phenobarbital / scopolamine)
- Hyrimoz (adalimumab)
More about cobimetinib
- cobimetinib consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.